Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | SPR | P35270 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | VNN1 | O95497 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13873199 | 0.93 | SPR (0.54) | FAAHMEN1KMT2ASPRSMN1; SMN2 | |
| SCHEMBL13873044 | 0.85 | MEN1 (0.67) | FAAHMEN1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL22317619 | 0.84 | CYP3A4 (0.52) | FAAHSPRALDH1A1VNN1 | |
| SCHEMBL19658651 | 0.83 | SPR (0.55) | SPRVNN1 | |
| SCHEMBL13873102 | 0.82 | ALDH1A1 (0.66) | MEN1KMT2APOLBALDH1A1LMNA | |
| SCHEMBL2280397 | 0.81 | GPR119 (0.61) | SPRLMNA | |
| SCHEMBL13873127 | 0.80 | ALDH1A1 (0.55) | MEN1KMT2APOLBALDH1A1LMNA | |
| SCHEMBL19658664 | 0.80 | EPHX2 (0.56) | MEN1KMT2ASPRALDH1A1VNN1 | |
| SCHEMBL13873680 | 0.79 | MEN1 (0.59) | FAAHMEN1KMT2APOLBSMN1; SMN2 | |
| SCHEMBL19652149 | 0.79 | SPR (0.51) | MEN1KMT2ASPRPOLBVNN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090111791-A1 | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-30 | — | — | US | disclosed |
| US-20090111791-A1 | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111791-A1 | Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same | EPHX1, EPHX2, NCEH1 | FAAH 11/4885MEN1 4174/4885KMT2A 3145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.